A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children

British Journal of Clinical Pharmacology

Volumn 50, Issue 2, 2000, Pages 125-134

  Anderson, Brian J ^a   Woollard, Gerald A ^b   Holford, Nicholas H G ^c  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Allometry; Comparative bioavailability; NONMEM; Paediatric; Paracetamol; Population pharmacokinetics

Indexed keywords

GELATIN; MORPHINE; PARACETAMOL; TRIACYLGLYCEROL;

ARTICLE; CHILD; CLINICAL TRIAL; CONSTANTS AND COEFFICIENTS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; ELIXIR; HUMAN; INFANT; LIVER TOXICITY; NEWBORN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACETAMINOPHEN; AGE FACTORS; ANALGESICS, NON-NARCOTIC; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; MODELS, BIOLOGICAL;

EID: 0033860767     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00231.x     Document Type: Article

References (42)

1. 1 Miller RP, Roberts RJ, Fischer LT. Acetaminophen elimination kinetics in neonates, children and adults. Clin Pharmacol Ther 1976; 19: 284-294.
2. 2 Hopkins CS, Underhill S, Booker PD. Pharmacokinetics of paracetamol after cardiac surgery. Arch Dis Child 1990; 65: 971-976.
3. 3 Levy G, Khanna NN, Soda DM, Tsuzuki O, Stern L. Pharmacokinetics of acetaminophen in the human neonate; formation of acetaminophin glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucoric acid excretion. Pediatrics 1975; 55: 818-825.
4. 4 Autret E, Dutertre JP, Breteau M, Jonville AP, Furet Y, Laugier J. Pharmacokinetics of paracetamol in the neonate and infant after administration of propacetamol chlorhydrate. Dev Pharmacol Ther 1993; 20: 129-134.
5. 5 Anderson B, Anderson M, Hastie B. Paracetamol prescribing habits in a children's hospital. N Z Med J 1996; 109: 376-378.
6. 6 Holford NH. The target concentration approach to clinical drug development. Clin Pharmacokin 1995; 29: 287-291.
7. 7 Anderson BJ, Woolard GA, Holford NH. Pharmacokinetics of rectal paracetamol after major surgery in children. Paediatr Anaesth 1995; 5: 237-242.
8. 8 Anderson BJ, Holford NH, Woollard GA, Chan PL. Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol 1998; 46: 237-243.
9. 9 Anderson BJ, Holford NH, Woollard GA, Kanagasundaram S, Mahadevan M. Perioperative pharmacodynamics of acetaminophen analgesia in children. Anesthesiology 1999; 90: 411-421.
10. 10 Sheiner LB, Beal SL. NONMEM Users Guide. San Francisco: Division of Pharmacology: University of California; 1979.
11. 11 Holford NHG. A size standard for pharmacokinetics. Clin Pharmacokin 1996; 30: 329-332.
12. 12 Peters HP. Physiological correlates of size. In The ecological implications of body size, Chapter 4, eds Beck E, Birks HJB, Conner EF. Cambridge: Cambridge University Press, 1983: 48-53.
13. 13 Prothero JW. Scaling of blood parameters in animals. Comp Biochem Physiol 1980; A67: 649-657.
14. 14 Gabrielsson J, Weiner D. Interspecies scaling. In Pharmacokinetic and pharmacodynamic data analysis, eds Gabrielsson J. Weiner D. Stockholm: Swedish Pharmaceutical Press Ltd, 1994: 153-171.
15. 15 West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 1997; 276: 122-126.
16. 16 Shann F. Paracetamol: when, why and how much. J Paediatr Child Health 1993; 29: 84-85.
17. 17 Kearns GL, Leeder JS, Wasserman GS. Acetaminophen overdose with therapeutic intent. J Pediatr 1998; 132: 5-8.
18. 18 Brown RD, Wilson JT, Kearns GL, Eichler VF, Johnson VA, Bertrand KM. Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol 1992; 32: 231-241.
19. 19 Wilson JT, Brown RD, Kearns GL, et al. Single-dose, placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children. J Pediatr 1991; 119: 803-811.
20. 20 West GB, Brown JH, Enquist BJ. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999; 284: 1677-1679.
21. 21 Pokela ML, Olkkola KT, Seppala T, Koivisto M. Age-related morphine kinetics in infants. Dev Pharmacol Ther 1993; 20: 26-34.
22. 22 Anderson BJ, McKee AD, Holford NH. Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clin Pharmacokin 1997; 33: 313-327.
23. 23 Prescott LF. Paracetamol (Acetaminophen) A Critical Bibliographic Review 1st edn. London. Taylor & Francis Publishers, 1996.
24. 24 van Bree JB, de Boer AG, Danhof M, Ginsel LA, Breimer DD. Characterization of an 'in vitro' blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. J Pharmacol Exp Ther 1988; 247: 1233-1239.
25. 25 Ochs HR, Greenblat DJ, Abernathy DR, et al. Cerebrospinal fluid uptake and peripheral distribution of centrally acting drugs: relation to lipid solubility. J Pharm Pharmacol 1985; 37: 428-431.
26. 26 Gupta M, Brans Y. Gastric retention in neonates. Pediatrics 1978; 62: 26-29.
27. 27 Grand RJ, Watkins JB, Torti FM. Development of the human intestinal tract: a review. Gastroenterology 1976; 70: 790-810.
28. 28 Forrest JA, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokin 1982; 7: 93-107.
29. 29 Nimmo WS, Heading RC, Wilson J, Tothill P, Prescott LF. Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol 1975; 2: 509-513.
30. 30 Coulthard KP, Nielson HW, Schroder M, et al. Relative bioavailability and plasma paracetamol profiles of Panadol suppositories in children. J Paediatr Child Health 1998; 34: 425-431.
31. 31 Rawlins MD, Henderson BD, Hijab AR. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol 1977; 11: 283-286.
32. 32 van Hoogdalem EJ, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions. Clin Pharmacokin 1991; 21: 110-128.
33. 33 Moolenar F, Schoonen AJM, Everts A, Huizinga T. Absorption rate and bioavailability from fatty suppositories. Pharmaceutisch Weekblod Sci Edition 1979; 112: 89-94.
34. 34 Seideman P, Alvan G, Andrews RS, Labross A. Relative bioavailability of a paracetamol suppository. Eur J Clin Pharmacol 1980; 17: 465-468.
35. 35 Birmingham PK, Tobin MJ, Henthorn TK, et al. Twenty-four-hour pharmacokinetics of rectal acetaminophen in children: an old drug with new recommendations. Anesthesiology 1997; 87: 244-252.
36. 36 Heubi JE, Bien JP. Acetaminophen use in children: more is not better. J Pediatr 1997; 130: 175-177.
37. 37 Penna A, Buchanan N. Paracetamol poisoning in children and hepatotoxicity. Br J Clin Pharmacol 1991; 32: 143-149.
38. 38 Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 1998; 132: 22-27.
39. 39 Rivera Penera T, Gugig R, Davis J, et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 1997; 130: 300-304.
40. 40 Warner A. Drug use in the neonate: interrelationships of pharmacokinetics, toxicity, and biochemical maturity. Clin Chem 1986; 32: 721-727.
41. 41 Greene JW, Craft L, Ghishan F. Acetaminophen poisoning in infancy. Am J Dis Child 1983; 137: 386-387.
42. 42 Slattery JT, Nelson SD, Thummel KE. The complex interaction between ethanol and acetaminophen. Clin Pharmacol Ther 1996; 60: 241-246.